Intel’s 22% share plunge drags down global chip stocks from TSMC to Samsung

Intel’s 22% share plunge drags down global chip stocks from TSMC to Samsung


Pat Gelsinger, chief executive officer of Intel Corp., speaks during the Computex conference in Taipei, Taiwan, on Monday, June 4, 2024. Gelsinger took the stage at the Computex show in Taiwan to talk about new products he expects will help turn back the tide of share losses to peers, including AI leader Nvidia Corp. Photographer: Annabelle Chih/Bloomberg via Getty Images

Bloomberg | Bloomberg | Getty Images

Global semiconductor stocks fell on Friday after a lackluster set of results from U.S. chip firm Intel sent its shares cratering, and a global market sell-off weighed on tech names.

Intel shares fell 21.51% at 04:37 a.m. ET in premarket trade in the U.S. on Friday, after the company reported a big miss on earnings in the June quarter and said that it would lay off over 15% of its employees as part of a $10 billion cost-reduction plan.

In Asia, Taiwan Semiconductor Manufacturing Co. — known as TSMC — closed 4.6% lower in Taiwan, and Samsung was also more than 4% lower at the end of the session in South Korea. TSMC is the world’s biggest manufacturer of chips, while Samsung is the largest memory semiconductor firm globally.

Samsung rival SK Hynix, which supplies U.S. giant Nvidia, also fell sharply to close more than 10% lower.

The sell-off continued in Europe. Shares of ASML, which sells key tools required to make cutting-edge chips, were more than 6% lower at around 4:23 a.m. ET, in the Netherlands. ASMI, which also trades in the Netherlands, was off by 9%. STMicroelectronics and Infineon were both lower.

Intel’s results add to the mixed picture across the semiconductor sector, where companies like AMD and Nvidia continue to prosper from the boom in artificial intelligence. Other players, like Qualcomm and Arm, are not yet reaping the benefits of the technology in their financial results.

Adding to the pressure on chip stocks is a global equity sell-off that began in the U.S. and has fed its way through to Asia and Europe. This especially weighed on tech-heavy Nasdaq and on chip stocks.

The VanEck Semiconductor ETF, which includes major names in the sector, closed roughly 6.5% lower in the U.S. on Thursday.

A number of major U.S. chip names also fell on Friday in U.S. pre-market trade, with Nvidia trading around 3% lower.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More